These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1410853)

  • 1. Nephrocalcinosis caused by hyperparathyroidism in progression of renal failure: treatment with calcitriol.
    Nagode LA; Chew DJ
    Semin Vet Med Surg Small Anim; 1992 Aug; 7(3):202-20. PubMed ID: 1410853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of calcitriol therapy and serum phosphorus control in dogs and cats with chronic renal failure. Both are essential to prevent of suppress toxic hyperparathyroidism.
    Nagode LA; Chew DJ; Podell M
    Vet Clin North Am Small Anim Pract; 1996 Nov; 26(6):1293-330. PubMed ID: 8911021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure.
    Hostutler RA; DiBartola SP; Chew DJ; Nagode LA; Schenck PA; Rajala-Schultz PJ; Drost WT
    J Vet Intern Med; 2006; 20(6):1307-13. PubMed ID: 17186842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcemia in the dog and cat.
    Drazner FH
    J Am Vet Med Assoc; 1981 Jun; 178(12):1252-6. PubMed ID: 7196906
    [No Abstract]   [Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal secondary hyperparathyroidism in dogs.
    Stillion JR; Ritt MG
    Compend Contin Educ Vet; 2009 Jun; 31(6):E8. PubMed ID: 19746344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feline chronic renal failure: calcium homeostasis in 80 cases diagnosed between 1992 and 1995.
    Barber PJ; Elliott J
    J Small Anim Pract; 1998 Mar; 39(3):108-16. PubMed ID: 9551377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
    Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ
    Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and chronic renal failure.
    Ross LA
    Semin Vet Med Surg Small Anim; 1992 Aug; 7(3):221-6. PubMed ID: 1410854
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term control of plasma calcitriol concentration in dogs and humans. Dominant role of plasma calcium concentration in experimental hyperparathyroidism.
    Hulter HN; Halloran BP; Toto RD; Peterson JC
    J Clin Invest; 1985 Aug; 76(2):695-702. PubMed ID: 3928683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD.
    Quarles LD; Yohay DA; Carroll BA; Spritzer CE; Minda SA; Bartholomay D; Lobaugh BA
    Kidney Int; 1994 Jun; 45(6):1710-21. PubMed ID: 7933819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dietary phosphate restriction on renal secondary hyperparathyroidism in the cat.
    Barber PJ; Rawlings JM; Markwell PJ; Elliott J
    J Small Anim Pract; 1999 Feb; 40(2):62-70. PubMed ID: 10088085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal failure and hyperparathyroidism in an Alaskan Malamute pup.
    Burk RL; Barton CL
    J Am Vet Med Assoc; 1978 Jan; 172(1):69-72. PubMed ID: 624665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of metabolic bone disease in the pre-end-stage renal disease setting.
    Coburn JW; Elangovan L
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of modified protein diets in dogs and cats with chronic renal failure: current status.
    Polzin DJ; Osborne CA; Adams LG
    J Nutr; 1991 Nov; 121(11 Suppl):S140-4. PubMed ID: 1941209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of metastatic calcification in the paws of a cat with successful dietary management of renal hyperparathyroidism.
    Jackson HA; Barber PJ
    J Small Anim Pract; 1998 Oct; 39(10):495-7. PubMed ID: 9816574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal handling of calcium and phosphorus in experimental renal hyperparathyroidism in dogs.
    García-Rodríguez MB; Pérez-García CC; Ríos-Granja MA; Cano-Rábano MJ; Peña-Penabad M; Gallego-Morales D; García-Partida P; Diez-Prieto I
    Vet Res; 2003; 34(4):379-87. PubMed ID: 12911855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in dogs with chronic renal failure.
    Takahashi F; Furuichi T; Yorozu K; Kawata S; Kitamura H; Kubodera N; Slatopolsky E
    Nephrol Dial Transplant; 2002; 17 Suppl 10():46-52. PubMed ID: 12386269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study.
    Evenepoel P; Sprangers B; Lerut E; Bammens B; Claes K; Kuypers D; Meijers B; Vanrenterghem Y
    Clin Transplant; 2012; 26(3):393-402. PubMed ID: 22007637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.